Ora Pharm ltd

Ora Pharm Limited

Early Stage Capital

Register Interest


The law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors make an informed decision.

If you are an accredited investor under the definition of that term in Rule 501(a) of Regulation D of the US Securities Act of 1933, the usual rules do not apply to offers of financial products made to you. As a result, you may not receive a complete and balanced set of information.

You will also have fewer other legal protections for these investments. Ask questions, read all documents carefully, and seek independent financial advice before committing yourself.

Transaction Size
NZD 7,200,000.00
Share Price
Minimum Investment
NZD 50,000.00
Issue Type
Early Stage Capital
Health Care

The opportunity exists for Wholesale Investors to express interest in Ora Pharm Limited (Ora Pharm)

The Company

Ora Pharm is ideally positioned to become the leading New Zealand supplier of high value, pharmaceutical grade medicinal cannabis products to meet rapidly growing international and domestic demand. Ora Pharm is secured a location in North Waikato that is ideally suited to growing cannabis, both indoors (year-round) and outdoors (seasonally). Using specialized greenhouses developed in the US but little-known in the Southern Hemisphere, Ora Pharm is preparing to own the most efficient and productive growing facilities for cannabis in New Zealand.

In a market with very high regulatory barriers to entry and competitors beginning to operate, Ora Pharm stands out as the only company with significant market experience and a strong US market platform to drive growth. Zoe Reece (CEO and Founder) and Stuart Wilcox (Executive Chairman and Head of International Business Development) bring a wealth of experience having previously held senior executive positions at Curaleaf, one of the largest and most respected cannabis corporation in North America with a market capitalisation of over US$11.5 billion.

The Offer

Ora Pharm is seeking to raise up to NZ$7.2 million in equity capital through a Series A Funding Round from wholesale and institutional investors. The capital raised will support the expansion of cultivation capacity, develop processing and manufacturing capability and the freehold purchase of land.

For more information please refer to the Information Memorandum in the documents section.

To access further information and be put in contact with the arranger, Register Interest.

Ora Pharm Investor Presentation - June 2022
August 17, 2022

Join our Issuer newsletter

Our quarterly Issuer newsletter is for partners, businesses and anyone interested in what we’re up to, platform updates and market commentary. To sign up to the Investor newsletter for marketplace offers click here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.